May 31, 2019
Mucosta – API Insight, 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Mucosta – API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Mucosta – API Insight, 2019…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
May 31, 2019
Isentress – API Insight, 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Isentress – API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Isentress – API Insight, 2019…
May 31, 2019
Nexium – API Insight, 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Nexium – API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Nexium – API Insight, 2019…
May 31, 2019
Stallergenes Greer Will Be at 2019 EAACI Congress and Present the Results of Its Phase III House Dust Mites Tablet Trial
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/EAACI2019?src=hash" target="_blank"gt;#EAACI2019lt;/agt;–Stallergenes Greer today announced that house dust mite (HDM) induced allergic rhinitis, its treatment with sublingual tablets…
May 31, 2019
Beam Therapeutics, Bio Palette in license agreements for base editing technologies
Beam Therapeutics and Bio Palette today announced an exclusive
cross-license agreement around each companies’ base editing intellectual
property.
May 31, 2019
Elite High School Scientists Headed to BIO 2019 to Face Off in the BioGENEius Challenge
WASHINGTON–(BUSINESS WIRE)–Today, the Biotechnology Institute announced the 15 student winners who will advance to the final stages of the 2019…
May 31, 2019
Adaptive Biotechnologies appoints Kevin Conroy and Michelle Griffin to board of directors
Adaptive Biotechnologies today announced Kevin Conroy, chairman and CEO
of Exact Sciences Corporation, and Michelle Griffin, director at Acer
Therapeutics, Inc. and HTG Molecular Diagnostics, Inc., have been
elected to the board of directors. Board member Arnold J. Levine, PhD,
has transitioned to Adaptive’s scientific advisory board.
May 30, 2019
Schrödinger to Present at the Jefferies 2019 Global Healthcare Conference
Schrödinger
today announced that Ramy Farid, Ph.D., chief executive officer, will
present at the Jefferies 2019 Global Healthcare Conference on Thursday,
June 6, 2019 at 11:00 a.m. ET in New York, NY.
May 30, 2019
Lantheus Announces Strategic Collaboration with NanoMab to Provide a Novel Biomarker for Clinical Development and Management of Immuno-Oncology Therapies
Lantheus expands into immuno-oncology and pharmaceutical services business through the license of NanoMab’s NM-01, an anti-PD-L1 imaging biomarker, designed to…